All News
All Companies
English
All News /
Corporate News
Estithmar Holding Q.P.S.C. Signs an MOU with the Korean Ehlbio to Provide Stem Cell Therapies
2024-03-04

Estithmar Holding Q.P.S.C. Signs an MOU with the Korean Ehlbio to Provide Stem Cell Therapies

Estithmar Holding Q.P.S.C. signs an MoU with the Korean EHLBio through its subsidiary Elegancia Healthcare to provide stem cell therapies at the soon-to-be-opened KMC- Korean Medical Center in Lusail Boulevard. Press release attached
Source: QSE